Solid biosciences reports inducement grants under nasdaq listing rule 5635(c)(4)

Charlestown, mass., march 04, 2025 (globe newswire) -- solid biosciences inc. (nasdaq: sldb) (the “company”), a life sciences company developing precision genetic medicines for neuromuscular and cardiac diseases, today announced a grant of 11,950 restricted stock units (“rsus”) to one newly hired employee.
SLDB Ratings Summary
SLDB Quant Ranking